A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death

Allison R.Balaj; Hiroaki Kaku

doi:10.4103/NRR.NRR-D-23-01934

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death

DOI: 10.4103/NRR.NRR-D-23-01934

A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death

Allison R.Balaj

Hiroaki Kaku

Machine-generated Keywords：

Publication Date：2024-12-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 2577-2578 )

Neural Regeneration Research

ISSN：1673-5374

Year, Vol.(Issue)：2024,19(12)